Cargando…
Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers
This first-in-humans study investigated the safety, biodistribution, and radiation dosimetry of a novel (18)F-labeled radiohybrid prostate-specific membrane antigen (rhPSMA) PET imaging agent, (18)F-rhPSMA-7.3. Methods: Six healthy volunteers (3 men, 3 women) underwent multiple whole-body PET acquis...
Autores principales: | Tolvanen, Tuula, Kalliokoski, Kari, Malaspina, Simona, Kuisma, Anna, Lahdenpohja, Salla, Postema, Ernst J., Miller, Matthew P., Scheinin, Mika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844263/ https://www.ncbi.nlm.nih.gov/pubmed/33067338 http://dx.doi.org/10.2967/jnumed.120.252114 |
Ejemplares similares
-
Kinetic analysis and optimisation of (18)F-rhPSMA-7.3 PET imaging of prostate cancer
por: Malaspina, Simona, et al.
Publicado: (2021) -
Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022) -
Pitfalls in PSMA imaging: [(18)F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
por: Feuerecker, B., et al.
Publicado: (2021) -
Automated synthesis of [(18)F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
por: Wurzer, Alexander, et al.
Publicado: (2021) -
Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)